Bmi-1 mRNA as a Prognostic Factor in Breast Cancer
Author Information
Author(s): Silva Javier, García Vanesa, García José M, Peña Cristina, Domínguez Gemma, Díaz Raquel, Lorenzo Yolanda, Hurtado Alicia, Sánchez Antonio, Bonilla Félix
Primary Institution: Hospital Universitario Puerta de Hierro
Hypothesis
Can Bmi-1 mRNA levels in plasma serve as a prognostic marker for advanced breast cancer patients?
Conclusion
Bmi-1 expression levels in plasma may indicate poor prognosis in breast cancer patients.
Supporting Evidence
- Bmi-1 mRNA was detected in 43.2% of breast cancer samples.
- Higher Bmi-1 levels correlated with poor clinical outcomes.
- The presence of Bmi-1 in plasma was associated with advanced disease stages.
Takeaway
This study found that measuring Bmi-1 in the blood of breast cancer patients could help doctors understand how serious the cancer is.
Methodology
Bmi-1 expression levels were quantified in plasma samples from 111 breast cancer patients and 20 healthy controls using real-time quantitative PCR.
Limitations
The study did not find a significant correlation between Bmi-1 presence and disease-free survival or overall survival in all patients.
Participant Demographics
111 breast cancer patients and 20 healthy controls.
Statistical Information
P-Value
0.019
Confidence Interval
95% CI, 87.62% to 99.38%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website